- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
EPIT
TLV
Week ended 07 Aug 2026
Weekly Investor Report
Epitomee Medical Ltd · Healthcare · Medical Devices
Latest close
3.44 ILA
-1.8%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -99.4% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -1.8%, after a -2.0% four-week move. The latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal.
Setup score
21
out of 100
Latest Close
3.44 ILA
7 Aug 2026
1W Return
-1.8%
latest completed week
4W Return
-2.0%
short-term follow-through
12W Return
-99.5%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.8%
Latest completed week; four-week move -2.0%.
Indicator stack
13/33
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
49/100
28 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -99.4% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -1.8%, after a -2.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.34
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.0% over four weeks, -99.5% over 12 weeks, and -99.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.04Latest activity-pressure read.
Pressure change19.5%Four-week change in activity pressure.
Leadership-99.51Latest relative-leadership reading.
RS change0.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment49/100
Weighted news tone is neutral across 28 relevant articles.
1 positive · 25 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.7%Distance below the 52-week high.
13-week volatility27.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+20.6%Week of 20 Mar.
Worst week-99.1%Week of 29 May.
Latest week-1.8%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains5
Flat weeks0
Modest losses9
Sharp losses9
Recent vol27.5%13-week weekly-return volatility.
Base vol15.6%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -8.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIL Healthcare
4-week rank25 / 50
Group average-3.5%
Trend breadth4.0%
Trend4.0%active weekly trend signals
MD20.0%positive activity pressure
RS2.0%positive relative leadership
Four-week leaders
IndustryIL Medical Devices
4-week rank4 / 10
Group average-7.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD20.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment49/100Weighted news tone is neutral across 28 relevant articles.
EPITOMEE MEDICAL LTD Revenue Breakdown – TASE:EPIT Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3.44 ILA | -1.8% | 536.5 ILA | 702.5 ILA | -1.04 | -99.51 | 67.9K | Off |
| 31 Jul 2026 | 3.50 ILA | 9.2% | 559.8 ILA | 708.0 ILA | -1.03 | -99.52 | 101.9K | Off |
| 24 Jul 2026 | 3.21 ILA | -0.9% | 580.9 ILA | 712.4 ILA | -1.06 | -99.58 | 67.2K | Off |
| 17 Jul 2026 | 3.24 ILA | -7.7% | 603.3 ILA | 716.5 ILA | -1.16 | -99.58 | 201.5K | Off |
| 10 Jul 2026 | 3.51 ILA | -16.0% | 625.3 ILA | 720.9 ILA | -1.30 | -99.55 | 535.3K | Off |
| 3 Jul 2026 | 4.18 ILA | -38.5% | 648.6 ILA | 725.5 ILA | -1.49 | -99.49 | 65.1K | Off |
| 26 Jun 2026 | 6.80 ILA | 0.9% | 673.0 ILA | 729.9 ILA | -1.61 | -99.17 | 0 | Off |
| 19 Jun 2026 | 6.74 ILA | -2.4% | 697.2 ILA | 734.2 ILA | -1.62 | -99.22 | 620 | Off |
| 12 Jun 2026 | 6.90 ILA | 2.8% | 721.0 ILA | 738.8 ILA | -1.47 | -99.26 | 3.1K | Off |
| 5 Jun 2026 | 6.71 ILA | -2.5% | 746.0 ILA | 745.9 ILA | -1.30 | -99.29 | 41.0K | Off |
| 29 May 2026 | 6.88 ILA | -99.1% | 770.0 ILA | 751.4 ILA | -1.08 | -99.32 | 71.0K | Off |
| 22 May 2026 | 770.1 ILA | 4.2% | 794.0 ILA | 757.0 ILA | -0.77 | -24.71 | 12.2K | Off |
| 15 May 2026 | 739.4 ILA | -7.8% | 791.7 ILA | 757.0 ILA | -0.53 | -28.52 | 44.2K | On |
| 8 May 2026 | 801.6 ILA | -5.2% | 793.2 ILA | 758.6 ILA | -0.15 | -25.92 | 39.0K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.